✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Lupin Ltd.

LUPIN

Market Cap
₹1,01,294 Cr.
P/E
18.99

Lupin Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1.01 L Cr
PE
PE
18.99
Prom Holding
Prom Holding
46.86 %
ROE (%)
ROE (%)
19.08
ROCE (%)
ROCE (%)
21.89
Div Yield (%)
Div Yield (%)
0.81
Sales
Sales
27,958 Cr
OPM (%)
OPM (%)
31.53 %
Debt to Equity
Debt to Equity
0.30
Institutions
Institutions
47.03 %
Individual < 2 lac
Individual < 2 lac
4.92 %
No. of Shareholders
No. of Shareholders
2.90 L
View more
Edit Ratio's

About

Lupin is a leading global pharmaceutical company based in Mumbai, India, specializing in brand… Read more
Low
1837
52W Range
High
2494
  • Lupin
  • Cipla
  • Dr. Reddy's Lab
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

13 Yes

Positive for this company

2 Neutral

Neutral for this company

2 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

8 %
(as of Mar 25)
Historic
Anti - Diabetes - Market Share
3.08 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.03 %
(as of May 19)
Historic
Anti-Malarial - Market Share
0.09 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
2.15 %
(as of Nov 21)
Historic
Blood Related - Market Share
6.10 %
(as of Mar 25)
Historic
Cardiovascular - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Acute vs Chronic

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Bharat Dynamics Ltd.
    • Navin Fluorine International Ltd.
    • Neuland Laboratories Ltd.
    • Shaily Engineering Plastics Ltd.
    • Borosil Renewables Ltd.

    FAQs on Lupin Ltd. Business

    Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in many markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health.

    Lupin major competitors are Mankind Pharma, Cipla, Dr. Reddy's Lab, Zydus Lifesciences, Aurobindo Pharma, Alkem Laboratories, Glenmark Pharma.
    Market Cap of Lupin is ₹1,02,691 Crs.
    While the median market cap of its peers are ₹95,592 Crs.

    Lupin seems to be less financially stable compared to its competitors.
    Altman Z score of Lupin is 7.79 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May May Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Dec
    Investor Presentation Feb May May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Jan Feb Mar May Jun Aug Sep Dec Jan Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Dec Mar
    Conference Call Feb Mar Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Lupin Ltd.
    View the discussion on ValuePickr
    Lupin - An Interesting Turnaround Story In Pharma Sector - Logical Investor
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material